The purpose of this review of clinical guidelines and best practices literature is to suggest prevention options and a treatment approach for intermittent catheter users that will minimize urinary tract infections (UTI). Recommendations are based both on evidence in the literature and an understanding of what is currently attainable within the Alberta context. This is done through collaboration between both major tertiary care centres (Edmonton and Calgary) and between various professionals who regularly encounter these patients, including nurses, physiatrists and urologists.
Bladder management in the context of a spinal cord injuryA pervasive issue in most neurologic diseases (Parkinson's disease, multiple sclerosis, diabetes, stroke and spinal cord injury [SCI]) is bladder dysfunction (neurogenic bladder) or neurogenic lower urinary tract dysfunction (NLUTD). These dysfunctions result in symptoms of urgency, increased daytime and nighttime frequency, urinary retention, incontinence and urinary tract infection (UTI). Treatment involves non-invasive continence management through toileting, fluid management, containment products, medications and intermittent catheterization. UTIs have substantial negative physical and psychological effects and are a major burden on the health care system. Frequent UTI in the SCI population is defined clinically as 3 or more infections per year where both symptoms of infection and a positive urine culture are present. Despite the variety of treatment approaches to emptying the neurogenic bladder, UTI remains a complex and challenging clinical problem.Intermittent catheterization (IC) is recognized as the gold standard for treating voiding disorders associated with the neurogenic bladder.